Showing results (161-170 of 406) with videos related to

Sort By:
Pageof 41
Blood Cells, Molecules & Diseases|September 18, 2007
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an updateWolfgang A Bethge, Christoph Faul, Martin Bornhäuser, et al.
Leukemia & Lymphoma|January 4, 2018
Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancersJuliane Sarah Walz, Daniel Johannes Kowalewski, Linus Backert, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)Daniel J Kowalewski, Heiko Schuster, Linus Backert, et al.
Annals of Hematology|August 3, 2016
Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantationMatyas Ecsedi, Jörg Schmohl, Robert Zeiser, et al.
Experimental Hematology|April 27, 2005
Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinibUlrike Hartmann, Stefan Balabanov, Patrick Ziegler, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 23, 2025
Value of Spectral CT Techniques for the Assessment of Bone Marrow Infiltration in Multiple Myeloma: A Systematic Literature ReviewYasmin Fede Melzer, Jennifer Erley, Inka Ristow, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2023
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial SubanalysisSalomon Manier, Meletios Dimopoulos, Cyrille Hulin, et al.
British Journal of Haematology|November 24, 2016
Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMTOlle Ringdén, Myriam Labopin, Christoph Schmid, et al.
British Journal of Haematology|July 20, 2024
Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real-world evidenceMonique A Hartley-Brown, Katja Weisel, Jacopo Bitetti, et al.
Cancers|December 23, 2023
Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical TrialsEdward Laane, Sam Salek, Esther Natalie Oliva, et al.
Pageof 41